ID
23263
Beskrivning
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus
Nyckelord
Versioner (1)
- 2017-07-01 2017-07-01 -
Rättsinnehavare
Genentech, Inc.
Uppladdad den
1 juli 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
STUDY COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT00473382
STUDY COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT00473382
Beskrivning
STUDY COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED)
Beskrivning
DISC_COMPLETED_STUDY [DCCMP]
Datatyp
integer
Alias
- UMLS CUI [1]
- C2826674
Beskrivning
DISC_COMP_DT [DCCDT]
Datatyp
date
Måttenheter
- DD/MMM/YY
Alias
- UMLS CUI [1]
- C2983670
Beskrivning
DISC_PRIMARY_REASON [DCRS]
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C2348571
- UMLS CUI [1,2]
- C0566251
Beskrivning
DISC_PRIMARY_REAS_SP [DCRSP]
Datatyp
text
Alias
- UMLS CUI [1,1]
- C2348571
- UMLS CUI [1,2]
- C0566251
- UMLS CUI [1,3]
- C0184661
Similar models
STUDY COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT00473382
C2986440 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C0184661 (UMLS CUI [1,3])